Clinical Trial Update: Human Surfactant Treatment of Respiratory Distress Syndrome Bicenter Trial [Phase 3]

View source ↗

Summary

Phase 3 multicenter trial evaluating human surfactant treatment for respiratory distress syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Human surfactant treatment (exogenous human surfactant)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Lung Diseases, Respiratory Distress Syndrome | Phase 3 | Status: COMPLETED